Skip to content

Discovering Factors in the Clinical Study Journey of Patients With OCD

Understanding the Patient Perspective: An Observational Study on Experiences of OCD Clinical Trial Patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05881356
Enrollment
500
Registered
2023-05-31
Start date
2024-06-30
Completion date
2026-06-30
Last updated
2023-05-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obsessive-Compulsive Disorder, OCD

Keywords

OCD, Obsessive-Compulsive Disorder

Brief summary

This research aims to collect comprehensive data on the clinical trial experience of OCD patients. Its goal is to identify the factors that limit patients' ability to join or complete a trial successfully. Clinical trial participation often favors specific demographic groups, and limited research exists on the impact of trial attributes on participation. Therefore, this study aims to analyze data from various demographic groups and identify any recurring trends that could provide valuable insights for future OCD patients.

Interventions

None listed

Sponsors

Power Life Sciences Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed. * Participant has a diagnosis of OCD. * Willing and able to comply with scheduled visits, treatment schedule, laboratory tests and other requirements of the study.

Exclusion criteria

* Pregnant or lactating woman * Enrolled in another research study * Any mental or medical condition that prevents the patient from giving informed consent or participating in the trial

Design outcomes

Primary

MeasureTime frame
Rate of participants who decide to enroll in a OCD clinical study.3 months
Number of OCD patients who remain in clinical trial until completion.12 months

Countries

United States

Contacts

Primary ContactMichael B Gill
bask@withpower.com415-900-4227

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026